Abstract
Diagnosis of congenital rubella infection which is realized in authorized laboratory, must be established in pregnant women with proven acute rubella infection. This diagnosis should also be considered in any infant presenting evidence of intrauterine growth retardation, or with others consistent signs of congenital infection. Presence of rubella-specific IgM antibody in fetal blood or presence of viral genomic RNA in amniotic fluid confirms the diagnosis so that accurate counselling can be offered to pregnant woman about the risks and damage to the fetus.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have